ONCOGENEX PHARMACEUTICALS, INC. 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Jun 21, 2010
Insider Transaction Report
Form 4
MARTINO MICHAEL A
Director
Transactions
- Sale
Common Stock
2010-06-17−4,833→ 11,000 total - Exercise/Conversion
Common Stock
2010-06-17$6.66/sh+1,073$7,146→ 12,073 total - Exercise/Conversion
stock option (right to buy)
2010-06-17−1,073→ 0 totalExercise: $6.66From: 2008-03-18Exp: 2018-03-18→ Common Stock (1,073 underlying) - Exercise/Conversion
Common Stock
2010-06-17$7.25/sh+3,760$27,260→ 15,833 total - Exercise/Conversion
Stock option (right to buy)
2010-06-17−3,760→ 4,500 totalExercise: $7.25From: 2009-05-12Exp: 2016-05-12→ Common Stock (3,760 underlying)
Footnotes (1)
- [F1]This is the weighted average price. The prices ranged from $14.00 to $14.25. The reporting person undertakes to provide on request a detailed breakout of the pricing.